Ferring Inc.

1. Michael Scheiber Reproductive Endocrinology · Cincinnati, OH $13,227 3 payments
2. Stephen Boorjian Urology · Rochester, MN $4,340 1 payment
3. Sahil Khanna Gastroenterology · Rochester, MN $2,790 1 payment

1. Menopur Reproductive Health $13,227 65% · 1 recipient
2. Adstiladrin Oncology $4,340 21% · 1 recipient
3. Rebyota Gastroenterology $2,790 14% · 1 recipient

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

1. Reproductive Endocrinology Obstetrics & Gynecology $13,227 65% · 1 practitioner
2. Urology $4,340 21% · 1 practitioner
3. Gastroenterology Internal Medicine $2,790 14% · 1 practitioner

Each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

1. Ohio $13,227 65% · 1 recipient
2. Minnesota $7,130 35% · 2 recipients

Each share is of this company’s general payments in 2025 where a state was reported.

1. Consulting Fee $27,943 5 payments
2. Travel and Lodging $725 2 payments
3. Food and Beverage $110 4 payments

1. Ferring Pharmaceuticals Inc. NJ, United States $12,169,396
2. Ferring Pharmaceuticals AS Denmark $509,670
3. Ferring International Pharmascience Center US NJ, United States $371,012
4. Ferring Holding Inc. NJ, United States $365,851
5. Ferring International Center SA Switzerland $292,643
6. Ferring Pharmaceuticals Private Ltd India $64,489
7. Ferring Research Institute Inc. CA, United States $60,580
8. Ferring Microbiome Inc. MN, United States $51,415
9. Ferring Pharmaceuticals SA Rep Office Middle East Jordan $50,269
10. Ferring SA de CV Mexico $33,121

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent. The largest 10 of 23.